US 6,602,504 B2 · Canine coronavirus S gene and uses therefor

Abstract

The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.

Claims2

Dependent claims

A purified and isolated polypeptide that comprises the full length S protein of canine coronavirus (CCV) Strain 1-71, (SEQ ID NO:2).

Dependencies are inferred from the claim text.

Facts

Application

09/972,484Filed 5 Oct 2001 · division

Priority

14 Nov 1990

Published

US 2002/0127245 A112 Sep 2002

Granted

5 Aug 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
C07K 16/1145
Lentivirus , e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]: env proteins,…
A61K 38/00
Medicinal preparations containing peptides
A61K 39/00
Medicinal preparations containing antigens or antibodies

Family

Application07/613,066Parent of this continuation-in-part · filed 14 Nov 1990

Application07/698,927Parent of this continuation-in-part · filed 13 May 1991

Application07/880,194Parent of this continuation-in-part · filed 8 May 1992

Application08/331,625Parent of this continuation · filed 23 Nov 1994

Application09/494,151Parent of this division · filed 28 Jan 2000

US 2002/0127245 A1Pre-grant publication · published 12 Sep 2002

US 6,372,224 B1Parent of this division

Application09/494,151Parent of this continuation

US 6,057,436 AParent of this continuation

Application08/331,625Parent of this continuation-in-part

US 6,602,504 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

09/972,484Filed 5 Oct 2001 · division

Priority

14 Nov 1990

Published

US 2002/0127245 A112 Sep 2002

Granted

5 Aug 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
C07K 16/1145
Lentivirus , e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]: env proteins,…
A61K 38/00
Medicinal preparations containing peptides
A61K 39/00
Medicinal preparations containing antigens or antibodies

Family

Application07/613,066Parent of this continuation-in-part · filed 14 Nov 1990

Application07/698,927Parent of this continuation-in-part · filed 13 May 1991

Application07/880,194Parent of this continuation-in-part · filed 8 May 1992

Application08/331,625Parent of this continuation · filed 23 Nov 1994

Application09/494,151Parent of this division · filed 28 Jan 2000

US 2002/0127245 A1Pre-grant publication · published 12 Sep 2002

US 6,372,224 B1Parent of this division

Application09/494,151Parent of this continuation

US 6,057,436 AParent of this continuation

Application08/331,625Parent of this continuation-in-part

US 6,602,504 B2This patent

From the US filing history. Foreign family members aren’t listed.

Canine coronavirus S gene and uses therefor

Life of this patent

Abstract

Claims2

Canine coronavirus S gene and uses therefor

Life of this patent

Abstract

Claims2